Asymmetric dimethylarginine
Asymmetric dimethylarginine (ADMA) is a naturally occurring chemical found in blood plasma. It is a metabolic by-product of protein modification processes in the cells. ADMA is closely related to the amino acid L-arginine, a precursor of nitric oxide (NO), and plays a crucial role in the production of this important cellular signaling molecule.
ADMA is considered a marker for vascular endothelial dysfunction, which is often associated with several cardiovascular diseases, including hypertension, chronic heart failure, and atherosclerosis. It is also implicated in other conditions such as renal failure, diabetes, and pulmonary hypertension.
Biochemistry[edit]
ADMA is derived from proteins that have been post-translationally modified by the addition of methyl groups to the guanidine nitrogens of arginine residues. This process, known as arginine methylation, is carried out by a group of enzymes known as protein arginine methyltransferases (PRMTs).
ADMA is one of the products of this reaction, along with symmetric dimethylarginine (SDMA) and monomethylarginine (MMA). These molecules are released into the cytoplasm after proteolytic degradation of the parent proteins.
Physiological Role[edit]
ADMA inhibits the production of nitric oxide (NO) by competing with L-arginine for the active site of the enzyme nitric oxide synthase (NOS). NO is a crucial vasodilator, and reduced levels of NO in the blood vessels can lead to endothelial dysfunction and cardiovascular disease.
Clinical Significance[edit]
Elevated levels of ADMA in the blood plasma are associated with endothelial dysfunction, which is a key factor in the development of atherosclerosis and other cardiovascular diseases. ADMA levels are also elevated in conditions such as renal failure, diabetes, and pulmonary hypertension.
See Also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


